Saxagliptin N-methyl is a structurally related impurity derived from saxagliptin, characterized by a methyl substitution at the pyrrolidine nitrogen. This modification introduces a tertiary amine center while retaining the core 5-(4-fluorophenyl)-1-((2S)-2-((3R)-3-hydroxy-1-oxo-4-phenylbutyl)pyrrolidin-2-yl)-1H-1,2,3-triazole-4-carboxamide scaffold. The N-methyl substitution alters the compound's lipophilicity and hydrogen-bonding capacity compared to the parent drug. It arises as a synthetic byproduct during saxagliptin production via nucleophilic alkylation of the pyrrolidine nitrogen. This impurity serves as a critical HPLC reference standard for quantifying N-methylation byproducts in saxagliptin active pharmaceutical ingredient (API) batches.
On Request